“…QRT-PCR was performed for a panel of genes previously reported to be miR-29 targets, seed-matched target genes of miR-29, and/or genes consistent with the expected mechanism of action of miR-29 in repressing collagen/ECM expression (Boon et al, 2011;Cheng et al, 2013;Kriegel et al, 2012;Zhu et al, 2016a) and cell proliferation/differentiation (Roderburg et al, 2011;Wei et al, 2013, Zhu et al, 2016a. These genes include numerous collagens, elastin, transforming growth factor (TGF)-b isoforms, the Notch inhibitor Numb (Flores et al, 2014), the antifibrotic proteoglycan SDC4 (Jiang et al, 2010), the ECM receptor ITGA3 (Jiang et al, 2010;Longmate et al, 2017), the lamin B receptor LBR (Arai et al, 2016) and the plasma membrane trafficking regulator SNX27 (Yang et al, 2018), and others (Supplementary Table S1 online). A dose-dependent regulation of those PD biomarkers was observed ( Figure 1) in vivo via QRT-PCR.…”